These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 39424571

  • 1. The effect of intensive praziquantel administration on vaccine-specific responses among schoolchildren in Ugandan schistosomiasis-endemic islands (POPVAC A): an open-label, randomised controlled trial.
    Nkurunungi G, Nassuuna J, Natukunda A, Zirimenya L, Walusimbi B, Zziwa C, Ninsiima C, Kabagenyi J, Kabuubi PN, van Dam GJ, Corstjens PLAM, Kayiwa J, Kizza M, Mutebe A, Nakazibwe E, Akello FA, Sewankambo M, Kiwanuka S, Cose S, Wajja A, Kaleebu P, Webb EL, Elliott AM, POPVAC trial team.
    Lancet Glob Health; 2024 Nov; 12(11):e1826-e1837. PubMed ID: 39424571
    [Abstract] [Full Text] [Related]

  • 2. The effect of BCG revaccination on the response to unrelated vaccines in urban Ugandan adolescents (POPVAC C): an open-label, randomised controlled trial.
    Nassuuna J, Zirimenya L, Nkurunungi G, Natukunda A, Zziwa C, Ninsiima C, Apule B, Onen C, Amongi S, Serubanja J, Tumwesige P, Nsubuga D, Amongin R, van Dam GJ, Corstjens PLAM, Kayiwa J, Kabagenyi J, Cose S, Wajja A, Kaleebu P, Webb EL, Elliott AM, POPVAC trial team.
    Lancet Glob Health; 2024 Nov; 12(11):e1849-e1859. PubMed ID: 39424573
    [Abstract] [Full Text] [Related]

  • 3. The effect of intermittent preventive treatment for malaria with dihydroartemisinin-piperaquine on vaccine-specific responses among schoolchildren in rural Uganda (POPVAC B): a double-blind, randomised controlled trial.
    Zirimenya L, Natukunda A, Nassuuna J, Nkurunungi G, Zziwa C, Ninsiima C, Kukundakwe C, Nankabirwa CM, Katushabe C, Namusobya LK, Oduru G, Kabami G, Kabali J, Kayiwa J, Kabagenyi J, van Dam GJ, Corstjens PLAM, Cose S, Wajja A, Staedke SG, Kaleebu P, Elliott AM, Webb EL, POPVAC trial team.
    Lancet Glob Health; 2024 Nov; 12(11):e1838-e1848. PubMed ID: 39424572
    [Abstract] [Full Text] [Related]

  • 4. Effect of intensive treatment for schistosomiasis on immune responses to vaccines among rural Ugandan island adolescents: randomised controlled trial protocol A for the 'POPulation differences in VACcine responses' (POPVAC) programme.
    Nkurunungi G, Zirimenya L, Nassuuna J, Natukunda A, Kabuubi PN, Niwagaba E, Oduru G, Kabami G, Amongin R, Mutebe A, Namutebi M, Zziwa C, Amongi S, Ninsiima C, Onen C, Akello F, Sewankambo M, Kiwanuka S, Kizindo R, Kaweesa J, Cose S, Webb E, Elliott AM, POPVAC trial team, POPVAC trial team principal investigator.
    BMJ Open; 2021 Feb 16; 11(2):e040426. PubMed ID: 33593768
    [Abstract] [Full Text] [Related]

  • 5. Pre-vaccination Schistosoma mansoni and hookworm infections are associated with altered vaccine immune responses: a longitudinal analysis among adolescents living in helminth-endemic islands of Lake Victoria, Uganda.
    Natukunda A, Zirimenya L, Nkurunungi G, Nassuuna J, Nkangi R, Mutebe A, Corstjens PLAM, van Dam GJ, Elliott AM, Webb EL.
    Front Immunol; 2024 Feb 16; 15():1460183. PubMed ID: 39267753
    [Abstract] [Full Text] [Related]

  • 6. Schistosome and malaria exposure and urban-rural differences in vaccine responses in Uganda: a causal mediation analysis using data from three linked randomised controlled trials.
    Natukunda A, Nkurunungi G, Zirimenya L, Nassuuna J, Zziwa C, Ninsiima C, Tumusiime J, Nyanzi R, Namutebi M, Kiwudhu F, van Dam GJ, Corstjens PLAM, Kizindo R, Nkangi R, Kabagenyi J, Nassanga B, Cose S, Wajja A, Kaleebu P, Elliott AM, Webb EL, POPVAC trial team.
    Lancet Glob Health; 2024 Nov 16; 12(11):e1860-e1870. PubMed ID: 39424574
    [Abstract] [Full Text] [Related]

  • 7. Effect of Schistosoma mansoni infection and its treatment on antibody responses to measles catch-up immunisation in pre-school children: A randomised trial.
    Tweyongyere R, Nassanga BR, Muhwezi A, Odongo M, Lule SA, Nsubuga RN, Webb EL, Cose SC, Elliott AM.
    PLoS Negl Trop Dis; 2019 Feb 16; 13(2):e0007157. PubMed ID: 30763405
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of single versus four repeated doses of praziquantel against Schistosoma mansoni infection in school-aged children from Côte d'Ivoire based on Kato-Katz and POC-CCA: An open-label, randomised controlled trial (RePST).
    Hoekstra PT, Casacuberta-Partal M, van Lieshout L, Corstjens PLAM, Tsonaka R, Assaré RK, Silué KD, Meité A, N'Goran EK, N'Gbesso YK, Amoah AS, Roestenberg M, Knopp S, Utzinger J, Coulibaly JT, van Dam GJ.
    PLoS Negl Trop Dis; 2020 Mar 16; 14(3):e0008189. PubMed ID: 32196506
    [Abstract] [Full Text] [Related]

  • 9. Efficacy, safety, and palatability of arpraziquantel (L-praziquantel) orodispersible tablets in children aged 3 months to 6 years infected with Schistosoma in Côte d'Ivoire and Kenya: an open-label, partly randomised, phase 3 trial.
    N'Goran EK, Odiere MR, Assandé Aka R, Ouattara M, Aka NAD, Ogutu B, Rawago F, Bagchus WM, Bödding M, Kourany-Lefoll E, Tappert A, Yin X, Bezuidenhout D, Badenhorst H, Huber E, Dälken B, Haj-Ali Saflo O.
    Lancet Infect Dis; 2023 Jul 16; 23(7):867-876. PubMed ID: 36893784
    [Abstract] [Full Text] [Related]

  • 10. Comparative efficacy of one versus two doses of praziquantel on cure rate of Schistosoma mansoni infection and re-infection in Mayuge District, Uganda.
    Tukahebwa EM, Vennervald BJ, Nuwaha F, Kabatereine NB, Magnussen P.
    Trans R Soc Trop Med Hyg; 2013 Jun 16; 107(6):397-404. PubMed ID: 23596262
    [Abstract] [Full Text] [Related]

  • 11. Repeated doses of Praziquantel in Schistosomiasis Treatment (RePST) - single versus multiple praziquantel treatments in school-aged children in Côte d'Ivoire: a study protocol for an open-label, randomised controlled trial.
    Hoekstra PT, Casacuberta Partal M, Amoah AS, van Lieshout L, Corstjens PLAM, Tsonaka S, Assaré RK, Silué KD, Meité A, N'Goran EK, N'Gbesso YK, Roestenberg M, Knopp S, Utzinger J, Coulibaly JT, van Dam GJ.
    BMC Infect Dis; 2018 Dec 14; 18(1):662. PubMed ID: 30547750
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of praziquantel in preschool-aged and school-aged children infected with Schistosoma mansoni: a randomised controlled, parallel-group, dose-ranging, phase 2 trial.
    Coulibaly JT, Panic G, Silué KD, Kovač J, Hattendorf J, Keiser J.
    Lancet Glob Health; 2017 Jul 14; 5(7):e688-e698. PubMed ID: 28619227
    [Abstract] [Full Text] [Related]

  • 13. Effect of maternal Schistosoma mansoni infection and praziquantel treatment during pregnancy on Schistosoma mansoni infection and immune responsiveness among offspring at age five years.
    Tweyongyere R, Naniima P, Mawa PA, Jones FM, Webb EL, Cose S, Dunne DW, Elliott AM.
    PLoS Negl Trop Dis; 2013 Jul 14; 7(10):e2501. PubMed ID: 24147175
    [Abstract] [Full Text] [Related]

  • 14. Kaposi's sarcoma-associated herpesvirus seropositivity is associated with parasite infections in Ugandan fishing communities on Lake Victoria islands.
    Nalwoga A, Webb EL, Chihota B, Miley W, Walusimbi B, Nassuuna J, Sanya RE, Nkurunungi G, Labo N, Elliott AM, Cose S, Whitby D, Newton R.
    PLoS Negl Trop Dis; 2019 Oct 14; 13(10):e0007776. PubMed ID: 31618208
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of single-dose artesunate plus sulfalene/pyrimethamine combined with praziquantel for the treatment of children with Schistosoma mansoni or Schistosoma haematobium in western Kenya: a randomised, open-label controlled trial.
    Obonyo CO, Rawago FO, Makworo NK, Muok EMO.
    Parasit Vectors; 2024 Jun 28; 17(1):279. PubMed ID: 38943214
    [Abstract] [Full Text] [Related]

  • 16. Oral artemether for prevention of Schistosoma mansoni infection: randomised controlled trial.
    Utzinger J, N'Goran EK, N'Dri A, Lengeler C, Xiao S, Tanner M.
    Lancet; 2000 Apr 15; 355(9212):1320-5. PubMed ID: 10776745
    [Abstract] [Full Text] [Related]

  • 17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K, Williams J, Qi YP, Gutman J, Yeung L, Mai C, Finkelstain J, Mehta S, Pons-Duran C, Menéndez C, Moraleda C, Rogers L, Daniels K, Green P.
    Cochrane Database Syst Rev; 2022 Feb 01; 2(2022):. PubMed ID: 36321557
    [Abstract] [Full Text] [Related]

  • 18. Insufficiency of annual praziquantel treatment to control Schistosoma mansoni infections in adult women: A longitudinal cohort study in rural Tanzania.
    Mishra P, Colombe S, Paul N, Mlingi J, Tosiri I, Aristide C, Gao J, Kashangaki P, Nagai H, Kalluvya SE, de Dood CJ, Corstjens PL, Mngara J, van Dam GJ, Downs JA.
    PLoS Negl Trop Dis; 2019 Nov 01; 13(11):e0007844. PubMed ID: 31751333
    [Abstract] [Full Text] [Related]

  • 19. Comparing one dose of HPV vaccine in girls aged 9-14 years in Tanzania (DoRIS) with one dose of HPV vaccine in historical cohorts: an immunobridging analysis of a randomised controlled trial.
    Baisley K, Kemp TJ, Kreimer AR, Basu P, Changalucha J, Hildesheim A, Porras C, Whitworth H, Herrero R, Lacey CJ, Schiller JT, Lucas E, Mutani P, Dillner J, Indangasi J, Muwonge R, Hayes RJ, Pinto LA, Watson-Jones D.
    Lancet Glob Health; 2022 Oct 01; 10(10):e1485-e1493. PubMed ID: 36113532
    [Abstract] [Full Text] [Related]

  • 20. Two-year longitudinal survey reveals high genetic diversity of Schistosoma mansoni with adult worms surviving praziquantel treatment at the start of mass drug administration in Uganda.
    Faust CL, Crotti M, Moses A, Oguttu D, Wamboko A, Adriko M, Adekanle EK, Kabatereine N, Tukahebwa EM, Norton AJ, Gower CM, Webster JP, Lamberton PHL.
    Parasit Vectors; 2019 Dec 27; 12(1):607. PubMed ID: 31881923
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.